SCHEMBL1129527

SCHEMBL1129527

CCCCCC=CCC=CCC=CCC=CCCCC(=O)NCCc1c[nH]c2ccc(O)cc12

nearest known ligand 1.00 ✓ in ChEMBL — recovers established targets

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TRPV1 Q8NER1 13/20 1.00
FAAH O00519 1/20 1.00
PTGS2 P35354 1/20 1.00
SPR P35270 2/20 0.59
MTNR1A P48039 2/20 0.59
ALDH1A1 P00352 2/20 0.58
MAPT P10636 2/20 0.58
HPGD P15428 2/20 0.58
KDM4E B2RXH2 1/20 0.58
CYP1A2 P05177 1/20 0.58
CYP3A4 P08684 1/20 0.58
CYP2D6 P10635 1/20 0.58
IDO1 P14902 1/20 0.58
BLM P54132 1/20 0.58
NOTUM Q6P988 1/20 0.58
NPSR1 Q6W5P4 1/20 0.58
MEN1 O00255 1/20 0.57
ALOX12 P18054 1/20 0.57
KMT2A Q03164 1/20 0.57
TRPM8 Q7Z2W7 1/20 0.57

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30178232 1.00 TRPV1 (1.00) TRPV1FAAHPTGS2SPRMTNR1A
SCHEMBL157036 1.00 TRPV1 (1.00) TRPV1FAAHPTGS2SPRMTNR1A
SCHEMBL3810578 1.00 TRPV1 (1.00) TRPV1FAAHPTGS2SPRMTNR1A
SCHEMBL14507405 0.94 TRPV1 (0.90) TRPV1FAAHPTGS2SPRMTNR1A
SCHEMBL23630280 0.89 TRPV1 (1.00) TRPV1FAAHPTGS2SPRMTNR1A
SCHEMBL23630266 0.89 TRPV1 (1.00) TRPV1FAAHPTGS2SPRMTNR1A
SCHEMBL23630268 0.89 TRPV1 (1.00) TRPV1FAAHPTGS2SPRMTNR1A
SCHEMBL23630267 0.89 TRPV1 (1.00) TRPV1FAAHPTGS2SPRMTNR1A
SCHEMBL1746356 0.89 TRPV1 (1.00) TRPV1FAAHPTGS2SPRMTNR1A
SCHEMBL3815737 0.89 TRPV1 (1.00) TRPV1FAAHPTGS2SPRMTNR1A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20200215085-A1 Method to Abate Acute Airway Hypersensitivity and Asthma Attacks AAZEINTX INC. (CA) 2020-07-09 US disclosed
US-10583119-B2 Compounds, compositions and methods for making the same SIGNUM BIOSCIENCES, INC. (US) 2020-03-10 US disclosed
US-20170266161-A1 COMPOUNDS, COMPOSITIONS AND METHODS FOR MAKING THE SAME SIGNUM BIOSCIENCES, INC. (US) 2017-09-21 US disclosed
US-9486441-B2 Compounds, compositions and methods for making the same SIGNUM BIOSCIENCES, INC. (US) 2016-11-08 US disclosed
CN-102014897-B Compound, compositions and its preparation method SIGNUM BIOSCIENCES, INC. (US) 2015-08-05 CN disclosed
EP-2282735-A1 COMPOUNDS, COMPOSITIONS AND METHODS FOR MAKING THE SAME Signum Biosciences, Inc. (US) 2011-02-16 EP disclosed
WO-2009132051-A1 COMPOUNDS, COMPOSITIONS AND METHODS FOR MAKING THE SAME SIGNUM BIOSCIENCES, INC. (US) 2009-10-29 WO disclosed
US-20090264496-A1 Compounds, Compositions and Methods for Making the Same SIGNUM BIOSCIENCES, INC. 2009-10-22 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090264496-A1 Compounds, Compositions and Methods for Making the Same PPP2CA, PPP4C, PPP6C TRPV1 4687/4885FAAH 4119/4885PTGS2 2722/4885
US-20170266161-A1 COMPOUNDS, COMPOSITIONS AND METHODS FOR MAKING THE SAME PPP2CA, PPP4C, PPP6C TRPV1 4687/4885FAAH 4119/4885PTGS2 2722/4885
US-10583119-B2 Compounds, compositions and methods for making the same PPP2CA, PPP4C, PPP6C TRPV1 4687/4885FAAH 4119/4885PTGS2 2722/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.